Pollok Nicole E, Peng Yi, Raj Nikhil, Walgama Charuksha, Crooks Richard M
Department of Chemistry, The University of Texas at Austin, 100 E. 24th St., Stop A1590, Austin, Texas, 78712-1224, USA.
ACS Appl Nano Mater. 2021 Oct 22;4(10):10764-10770. doi: 10.1021/acsanm.1c02207. Epub 2021 Oct 13.
In this paper we demonstrate the use of dual-shaped silver nanoparticles (AgNPs) as detection labels for electrochemical bioassays. The key finding is that by using AgNP labels having two different shapes simultaneously, the limit of detection (LOD) for the assays is lowered compared to using either of the two shapes separately. The two shapes were silver nanocubes (AgNCs) having edge lengths of 40 ± 4 nm and spherical AgNPs (sAgNPs) having diameters of 20 ± 3 nm. Two different bioassays were examined. In both cases the Ag labels were functionalized with antibodies. In the one assay, the labels are directly linked to a second antibody immobilized on magnetic beads. In the second assay, the antibodies on the AgNP labels and the antibodies on the magnetic beads are linked via a peptide. The peptide is N-terminal prohormone brain natriuretic peptide (NT-proBNP), which is a heart failure marker. The efficacy of the two electrochemical assays as a function of the ratio of the two labels was investigated using a galvanic exchange/anodic stripping voltammetry method. The key finding is that by optimizing the ratio of the two types of AgNP labels, it is possible to decrease the LOD of the assays without compromising the dynamic range compared to using either of the two labels independently. This made it possible to achieve the clinically relevant range for NT-proBNP analysis used by physicians for heart failure risk stratification.
在本文中,我们展示了双形状银纳米颗粒(AgNPs)作为电化学生物分析检测标记物的应用。关键发现是,通过同时使用具有两种不同形状的AgNP标记物,与单独使用两种形状中的任何一种相比,分析的检测限(LOD)降低了。这两种形状分别是边长为40±4nm的银纳米立方体(AgNCs)和直径为20±3nm的球形AgNPs(sAgNPs)。研究了两种不同的生物分析方法。在这两种情况下,Ag标记物都用抗体进行了功能化。在一种分析方法中,标记物直接与固定在磁珠上的第二抗体相连。在第二种分析方法中,AgNP标记物上的抗体和磁珠上的抗体通过一种肽相连。该肽是N端前体脑钠肽(NT-proBNP),它是一种心力衰竭标志物。使用恒电流交换/阳极溶出伏安法研究了两种电化学生物分析方法作为两种标记物比例函数的效能。关键发现是,通过优化两种类型AgNP标记物的比例,与单独使用两种标记物中的任何一种相比,在不影响动态范围的情况下,可以降低分析的LOD。这使得实现医生用于心力衰竭风险分层的NT-proBNP分析的临床相关范围成为可能。